World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends

Published by: Kalorama Information

Published: May. 1, 2008 - 250 Pages

Table of Contents

TABLE OF CONTENTS

• Background


• Scope and Methodology


• Size and Growth of the Market


• Key Issues and Trends Affecting Market


• Leading Competitors

• Background


• Distribution and Safety Issues in the United States


• Consumer Advertising/Promotion


• World Health and Life Expectancy


• Life Expectancy


• Birth Rates


• Tobacco Use


• Obesity


• Declining Growth of the World Population


• Prescription VS Over-the-Counter Industry


• Rx-to-OTC Switch Industry


• Rx-to-OTC Switch Forecast in the United States


• Economic Trends
  
  
  • Purchasing Power Trends
  
  
  • Challenges


• Health Insurance Issues and Trends


• Consumer Issues and Trends
  
  
  • U.S Consumers
  
  
  • Consumers around the World


• Access to Professional Medical Services and the Link to Self-Medication


• Regulatory Environment
  
  
  • Revisions to Pharmaceutical Affairs Law (PAL) in Japan
  
  
  • Russian Beneficiary Drug Provision Program
  
  
  • A Third Class of Drugs in the United States

Overview

• Demographics


• OTC Product Segments


• Market Analysis


• OTC Product Segment Market Analysis


• Markets by Country

• Overview


• Demographics


• OTC Product Segment


• Market Analysis


• OTC Product Segment Market Analysis


• Markets by Country

• Overview


• Demographics


• OTC Product Segments


• Market Analysis


• OTC Product Segment Market Analysis
  
• Markets by Country

• Overview


• Demographics


• OTC Product Segments


• Market Analysis


• OTC Product Segment Market Analysis


• Markets by Country

• Overview


• OTC Product Segment Market Analysis


• Markets by Country

• Overview


• Competitor Analysis


• Significant Mergers and Acquisitions


• Bristol-Myers Squibb and Novartis AG


• Johnson & Johnson and Pfizer


• Bayer and Roche


• Reckitt Benckiser and Adams Respiratory Therapeutics


• Reckitt Benckiser and Boots Healthcare


• Leading Corporate Profiles


• Bayer Healthcare AG


• Boehringer Ingelheim Gmbh


• Chattem, Inc.


• Glaxo Smith Kline


• Mc Neil Consumer (Johnson & Johnson)


• Novartis Consumer


• Procter & Gamble


• Reckitt Benckiser


• Sanofi-Aventis


• Schering-Plough


• Taisho Pharmaceutical


• Takeda Pharmaceutical


• Wyeth

LIST OF EXHIBITS

• Table 1-1: Total World OTC Market Analysis, 2005-2007


• Table 1-2: Forecasted Total World OTC Market Analysis: 2008-2012


• Figure 1-1: Total World OTC Market Analysis: 2005-2012

• Table 2-1: Average Life Expectancy in Years by Country 1980,
  2004 and Estimated 2006


• Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005
  and Projected 2010


• Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005
  and Projected 2010


• Table 2-3: Percent of Smokers by Country


• Figure 2-2: Average Percent of Smokers Worldwide
  in Developed Regions


• Table 2-4: Percent of Population that is Obese* in 2003, 2004
  and Estimated 2005


• Table 2-5: World Population 1980 to 2050


• Figure 2-3: World Population 1980 to 2050


• Table 2-6: Total Pharmaceutical Markets, Prescription vs.
  Non-Prescription by Region, 2007


• Figure 2-4: Total Pharmaceutical Markets, Prescription vs.
  Non-Prescription by Region, 2007


• Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2007


• Figure 2-5: Number of New Rx-to-OTC Switches in the
  United States, per Year 1976-2007


• Table 2-8: Potential Rx-to-OTC Switches, 2008-2013


• Table 2-9: Total Healthcare Expenditures as a Percent of GDP
  by Country 2004 and 2006


• Figure 2-6: Total Healthcare Expenditures as a Percent of GDP
  by Country 2004 and 2006


• Table 2-10: Gross National Income Comparison by Country 2000-2005


• Figure 2-7: Gross National Income Growth by Country 2000-2005


• Table 2-11: National Healthcare Expenditures in the United States 1960-2010


• Figure 2-8: Healthcare Spending as a Percent of GDP in the United States


• Table 2-12: Health Insurance Trends in the United States 2003-2006


• Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session

• Table 3-1: Population by Age Group for the Five Most Populated
  Countries in Asia-Pacific, Estimated 2007


• Table 3-2: Population by Age Group for the Five Most Populated
  Countries in Asia-Pacific, Projected 2012


• Figure 3-1: Population for the Five Most Populated Countries in
  Asia-Pacific, Estimated 2007 and Projected 2012


• Table 3-3: Population by Age Group for Africa, Estimated 2007 and 2012


• Figure 3-2: Population for Africa, Estimated 2007 and Projected 2012


• Table 3-4: Population by Gender for the Five Most Populated Countries
  in Asia-Pacific, Estimated 2007 and Projected 2012


• Figure 3-3: Population by Gender for Asia-Pacific, Estimated 2007
  and Projected 2012


• Table 3-5: Population by Gender for Africa, Estimated 2007 and
  Projected 2012


• Figure 3-4: Population by Gender for Africa, Estimated 2007 and
  Projected 2012


• Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and
  Africa (Product Name by Type and Marketer)


• Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of
  World Market, 2007 and 2012


• Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of
  World Market, 2007


• Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of
  World Market, 2012


• Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2007


• Table 3-9: Forecasted Asia-Pacific/Africa OTC Market Analysis: 2008-2012


• Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2012


• Table 3-10: Asia-Pacific/Africa OTC Market Analysis by
  Product Segment, 2005-2007


• Table 3-11: Forecasted Asia-Pacific/Africa OTC Market
  Analysis by Product Segment, 2008-2012


• Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by
  Product Segment, 2005-2012


• Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by
  Product Segment, 2007


• Table 3-12: Asia-Pacific/Africa OTC Market Analysis by
  Selected Country, 2007


• Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by
  Selected Country, 2007

• Table 4-1: Population by Age for the Five Most Populated
  Countries in Europe, Estimated 2007


• Table 4-2: Population by Age for the Five Most Populated
  Countries in Europe, Projected 2012


• Figure 4-1: Population for the Five Most Populated Countries in
  Europe, Estimated 2007 and Projected 2012


• Table 4-3: Population by Gender for the Five Most Populated
  Countries in Europe, Estimated 2007 and Projected 2012


• Figure 4-2: Population by Gender for Europe, Estimated 2007
  and Projected 2012


• Table 4-4: Examples of Marketed OTC Products in Europe
  (Product Name by Type and Marketer)


• Table 4-5: European OTC Market as a Percentage of World
  Market, 2007 and 2012


• Figure 4-3: European OTC Market as a Percentage of
  World Market, 2007


• Figure 4-4: European OTC Market as a Percentage of
  World Market, 2012


• Table 4-6: European OTC Market Analysis, 2005-2007


• Table 4-7: Forecasted European OTC Market Analysis: 2008-2012


• Figure 4-5: European OTC Market Analysis: 2005-2012


• Table 4-8: European OTC Market Analysis by Product
  Segment, 2005-2007


• Table 4-9: Forecasted European OTC Market Analysis by
  Product Segment, 2008-2012


• Figure 4-6: European OTC Market Analysis by Product
  Segment, 2005-2012


• Figure 4-7: European OTC Market Analysis by Product Segment, 2007


• Table 4-10: European OTC Market Analysis by Selected Country, 2007


• Figure 4-8: European OTC Market Analysis by Selected Country, 2007

• Table 5-1: Population by Age for the Five Most Populated Countries
  in North America, Estimated 2007


• Table 5-2: Population by Age for the Five Most Populated
  Countries in North America, Projected 2012


• Figure 5-1: Population for the Five Most Populated Countries in North
  America, Estimated 2007 and Projected 2012


• Table 5-3: Population by Gender for the Five Most Populated Countries
  in North America, Estimated 2007 and Projected 2012


• Figure 5-2: Population by Gender for North America, Estimated 2007
  and Projected 2012


• Table 5-4: Examples of Marketed OTC Products in North America
  (Product Name by Type and Marketer)


• Table 5-5: North American OTC Market as a Percentage of World
  Market, 2007 and 2012


• Figure 5-3: North American OTC Market as a Percentage of World
  Market, 2007


• Figure 5-4: North American OTC Market as a Percentage of World
  Market, 2012


• Table 5-6: North American OTC Market Analysis, 2005-2007


• Table 5-7: Forecasted North American OTC Market Analysis: 2008-2012


• Figure 5-5: North American OTC Market Analysis: 2005-2012


• Table 5-8: North American OTC Market Analysis by Product
  Segment, 2005-2007


• Table 5-9: Forecasted North American OTC Market
  Analysis by Product Segment, 2008-2012


• Figure 5-6: North American OTC Market Analysis |
  by Product Segment, 2005-2012


• Figure 5-7: North American OTC Market Analysis
  by Product Segment, 2007


• Table 5-10: North American OTC Market Analysis by
  Selected Country, 2007


• Figure 5-8: North American OTC Market Analysis by
  Selected Country, 2007

• Table 6-1: Population by Age for the Five Most Populated Countries in
  South America, Estimated 2007


• Table 6-2: Population by Age for the Five Most Populated Countries in
  South America, Projected 2012


• Figure 6-1: Population for the Five Most Populated Countries
  in South America, Estimated 2007 and Projected 2012


• Table 6-3:Population by Gender for the Five Most Populated Countries
  in South America, Estimated 2007 and Projected 2012


• Figure 6-2: Population by Gender for South America, Estimated 2007
  and Projected 2012


• Table 6-4: Examples of Marketed OTC Products in
  South America (Product Name by Type and Marketer)


• Table 6-5: South American OTC Market as a Percentage
  of World Market, 2007 and 2012


• Figure 6-3: South American OTC Market as a Percentage
  of World Market, 2007


• Figure 6-4: South American OTC Market as a Percentage
  of World Market, 2012


• Table 6-6: South American OTC Market Analysis, 2005-2007


• Table 6-7: Forecasted South American OTC Market Analysis: 2008-2012


• Figure 6-5: South American OTC Market Analysis: 2005-2012


• Table 6-8: South American OTC Market Analysis by Product
  Segment, 2005-2007


• Table 6-9: Forecasted South American OTC Market Analysis by
  Product Segment, 2008-2012


• Figure 6-6: South American OTC Market Analysis by Product
  Segment, 2005-2012


• Figure 6-7: South American OTC Market Analysis by Product
  Segment, 2007


• Table 6-10: South American OTC Market Analysis by Selected
  Country, 2007


• Figure 6-8: South American OTC Market Analysis by Selected
  Country, 2007

• Table 7-1: Total World OTC Market Analysis, 2005-2007


• Table 7-2: Forecasted Total World OTC Market Analysis: 2008-2012


• Figure 7-1: Total World OTC Market Analysis: 2005-2012


• Table 7-3: Total World OTC Market Analysis by Product
  Segment, 2005-2007


• Table 7-4: Forecasted Total World OTC Market Analysis by Product
  Segment, 2008-2012


• Figure 7-2: Total World OTC Market Analysis by Product
  Segment, 2005-2012


• Figure 7-3: Total World OTC Market Analysis by Product
  Segment, 2007


• Figure 7-4: Total World OTC Market Analysis by Product
  Segment, 2012


• Table 7-5: Top Ten World OTC Markets by Country, 2007


• Figure 7-5: Top Ten World OTC Markets by Country, 2007

• Table 8-1: Leading Suppliers Shares of the OTC Market and Significant
  Segments of Participation, 2007


• Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007

Abstract

• Analgesics
• Allergy, Cough, Cold, Flu Remedies
• Gastrointestinal Remedies
• Dermatologics
• Others (including: Smoking cessation products, Sleepaids, Dental rinses, fluorides, Hair growth remedies, Diet aids)

• Current Market Size and Forecasts by Product Type
• Regional Breakout of Revenues (including Asia Pacific and Africa, Europe, North America, South America regions)
• The Combined Wisdom of over 100 Market Experts interviewed for This Report
• Over 110 Figures and Tables to Make Points in the Text Clear
• Overview of Over the Counter Market
• Review of Successful OTC Products
• Market Share
• Company Profiles
• Discussion of Issues and Trends in OTC

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

The OTC market is vast with many competitors. The following main competitors are profiled in this report:

• Abbott Laboratories
• Novartis
• Wyeth
• Bayer Consumer Health
• Boehringer Ingelheim
• Chattem
• GlaxoSmithKline
• McNeil Consumer (Johnson & Johnson)
• Novartis Pharmaceuticals
• Procter & Gamble
• Reckitt Benckiser
• Sanofi-Aventis
• Schering-Plough
• Taisho Pharmaceutical
• Takeda
• Wyeth Consumer

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.